Autoantibodies to alpha-synuclein in inherited Parkinson’s disease (original) (raw)

Evolutive Immunologic and Toxicologic Approach in Some Neuroinflamatory and Degenerative Disease like SM, DA, PD

Evolutive Immunologic and Toxicologic Approach in Some Neuroinflamatory and Degenerative Disease like SM, DA, PD, 2020

alpha-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients

Plos One, 2011

Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson's Disease Relative to Alzheimer's Disease and Controls

Ali Shalash

Frontiers in neurology, 2017

View PDFchevron_right

An impedimetric assay of α-synuclein autoantibodies in early stage Parkinson's disease

Kevin Talbot

View PDFchevron_right

α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients

Marina Gruden, Ludmilla Morozova-roche

PLoS ONE, 2011

View PDFchevron_right

Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson's Disease: Correlation between Plasma and Cerebrospinal Fluid Levels

Ludmilla Morozova-Roche

ACS chemical neuroscience, 2017

View PDFchevron_right

Alpha-synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients

Vladimir Kostic

Movement Disorders, 2005

View PDFchevron_right

Corrigendum to ‘Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression’ [Journal of Neuroimmunology, 233 (2011) 221–227]

Ludmilla Morozova-Roche

Journal of Neuroimmunology, 2014

View PDFchevron_right

Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease

Kent Fitzgerald

PLoS ONE, 2013

View PDFchevron_right

Physiology and Pathology of Neuroimmunology: Role of Inflammation in Parkinson’s Disease

Fermín Pacheco-Moisés

Physiology and Pathology of Immunology, 2017

View PDFchevron_right

Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson’s Disease

Annemette Løkkegaard

Frontiers in Immunology

View PDFchevron_right

Alpha-synuclein and familial Parkinson's disease

Cheryl Halter

Movement Disorders, 2009

View PDFchevron_right

Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease

Leslie Shaw

Journal of neurochemistry, 2018

View PDFchevron_right

The Inflammatory Cytokines in the Pathogenesis of Parkinson’s Disease

Waleed Renno

Journal of Alzheimer's Disease & Parkinsonism, 2014

View PDFchevron_right

The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?

Shane Gao

Frontiers in Immunology, 2018

View PDFchevron_right

Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants

Mario Delgado

PLoS ONE, 2010

View PDFchevron_right

Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression

Robert Sewell

Journal of Neuroimmunology, 2011

View PDFchevron_right

Beta-synuclein gene variants and Parkinson's disease: A preliminary case-control study

Laura Brighina

Neuroscience Letters, 2007

View PDFchevron_right

CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers

Isabel Wurster

Frontiers in Neurology, 2022

View PDFchevron_right

Immunology, Autoimmunity, and Autoantibodies in Parkinson’s Disease

Joab Chapman

Clinical Reviews in Allergy & Immunology, 2012

View PDFchevron_right

Neuroinflammation in Parkinson's disease

Sayinthen Vivekanantham

View PDFchevron_right

Inflammation, Infectious Triggers, and Parkinson's Disease

SEPIDEH HOSSEINIPORGHAM

Front. Neurol, 2019

View PDFchevron_right

Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies

Marina Romero-ramos

Journal of Parkinson's Disease

View PDFchevron_right

Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics

Marco Cosentino

Frontiers in Neurology, 2019

View PDFchevron_right

Increased immune activation by pathologic alpha‐synuclein in Parkinson's Disease

Karin Danzer

Annals of Neurology

View PDFchevron_right

Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention

Sara Raquel Ferreira

Frontiers in cellular neuroscience, 2018

View PDFchevron_right

The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II

Thomas Gasser, Walter Rocca

Journal of Neuropathology and Experimental Neurology, 2007

View PDFchevron_right

Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology

GABRIEL MARTÍNEZ PASCUAL

Acta Neuropathologica, 2019

View PDFchevron_right

Etude de l'implication des cellules microgliales et de l'α-synucleine dans la maladie neurodégénérative de Parkinson

Henning Draheim

View PDFchevron_right

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

Vanesa Sanchez-guajardo, Marina Romero-ramos

ASN NEURO, 2013

View PDFchevron_right

α‐Synuclein induces apoptosis by altered expression in human peripheral lymphocytes in Parkinson’s disease

Seonghan Kim

The FASEB Journal, 2004

View PDFchevron_right

α-Synuclein in Parkinson’s disease: causal or bystander?

Wolfgang Jost

Journal of Neural Transmission, 2019

View PDFchevron_right

Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies

Lars Pedersen

Molecular neurodegeneration, 2017

View PDFchevron_right

Autoantibodies to alpha-synuclein in inherited Parkinson’s disease (original) (raw)

Related papers